These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31037322)

  • 1. Technological advancements for the development of stem cell-based models for hepatotoxicity testing.
    Natale A; Vanmol K; Arslan A; Van Vlierberghe S; Dubruel P; Van Erps J; Thienpont H; Buzgo M; Boeckmans J; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
    Arch Toxicol; 2019 Jul; 93(7):1789-1805. PubMed ID: 31037322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Metabolizing Activity of Human ES Cell-Derived Hepatocytes Using a 3D Culture System with Repeated Exposures to Xenobiotics.
    Kim JH; Jang YJ; An SY; Son J; Lee J; Lee G; Park JY; Park HJ; Hwang DY; Kim JH; Han J
    Toxicol Sci; 2015 Sep; 147(1):190-206. PubMed ID: 26089346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
    Gómez-Lechón MJ; Tolosa L
    Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing.
    Jin M; Yi X; Liao W; Chen Q; Yang W; Li Y; Li S; Gao Y; Peng Q; Zhou S
    Stem Cell Res Ther; 2021 Jan; 12(1):84. PubMed ID: 33494782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of omics-based human liver platforms for investigating the mechanism of drug-induced hepatotoxicity in vitro.
    Jiang J; Pieterman CD; Ertaylan G; Peeters RLM; de Kok TMCM
    Arch Toxicol; 2019 Nov; 93(11):3067-3098. PubMed ID: 31586243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional cultured liver-on-a-Chip with mature hepatocyte-like cells derived from human pluripotent stem cells.
    Kamei KI; Yoshioka M; Terada S; Tokunaga Y; Chen Y
    Biomed Microdevices; 2019 Jul; 21(3):73. PubMed ID: 31304567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cell types and culture methods on the functionality of in vitro liver systems - A review of cell systems for hepatotoxicity assessment.
    Kyffin JA; Sharma P; Leedale J; Colley HE; Murdoch C; Mistry P; Webb SD
    Toxicol In Vitro; 2018 Apr; 48():262-275. PubMed ID: 29408671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury.
    Donato MT; Tolosa L
    Differentiation; 2019; 106():15-22. PubMed ID: 30844688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicogenomics-based prediction of acetaminophen-induced liver injury using human hepatic cell systems.
    Rodrigues RM; Heymans A; De Boe V; Sachinidis A; Chaudhari U; Govaere O; Roskams T; Vanhaecke T; Rogiers V; De Kock J
    Toxicol Lett; 2016 Jan; 240(1):50-9. PubMed ID: 26497421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug-induced immune-mediated hepatotoxicity using hepatocyte-like cells derived from human embryonic stem cells.
    Kim DE; Jang MJ; Kim YR; Lee JY; Cho EB; Kim E; Kim Y; Kim MY; Jeong WI; Kim S; Han YM; Lee SH
    Toxicology; 2017 Jul; 387():1-9. PubMed ID: 28645575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally Enhanced Human Stem Cell Derived Hepatocytes in Galactosylated Cellulosic Sponges for Hepatotoxicity Testing.
    Tasnim F; Toh YC; Qu Y; Li H; Phan D; Narmada BC; Ananthanarayanan A; Mittal N; Meng RQ; Yu H
    Mol Pharm; 2016 Jun; 13(6):1947-57. PubMed ID: 27157693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human skin-derived stem cells as a novel cell source for in vitro hepatotoxicity screening of pharmaceuticals.
    Rodrigues RM; De Kock J; Branson S; Vinken M; Meganathan K; Chaudhari U; Sachinidis A; Govaere O; Roskams T; De Boe V; Vanhaecke T; Rogiers V
    Stem Cells Dev; 2014 Jan; 23(1):44-55. PubMed ID: 23952781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K; Mizuguchi H
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):12-20. PubMed ID: 28012798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell-Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury.
    Bell CC; Lauschke VM; Vorrink SU; Palmgren H; Duffin R; Andersson TB; Ingelman-Sundberg M
    Drug Metab Dispos; 2017 Apr; 45(4):419-429. PubMed ID: 28137721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pump-free microfluidic 3D perfusion platform for the efficient differentiation of human hepatocyte-like cells.
    Ong LJY; Chong LH; Jin L; Singh PK; Lee PS; Yu H; Ananthanarayanan A; Leo HL; Toh YC
    Biotechnol Bioeng; 2017 Oct; 114(10):2360-2370. PubMed ID: 28542705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current limitations and future opportunities for prediction of DILI from in vitro.
    Funk C; Roth A
    Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of hepatic spheroids using human hepatocyte-derived liver progenitor-like cells for hepatotoxicity screening.
    Wang Z; Li W; Jing H; Ding M; Fu G; Yuan T; Huang W; Dai M; Tang D; Zeng M; Chen Y; Zhang H; Zhu X; Peng Y; Li Q; Yu WF; Yan HX; Zhai B
    Theranostics; 2019; 9(22):6690-6705. PubMed ID: 31588244
    [No Abstract]   [Full Text] [Related]  

  • 18. Toward preclinical predictive drug testing for metabolism and hepatotoxicity by using in vitro models derived from human embryonic stem cells and human cell lines - a report on the Vitrocellomics EU-project.
    Mandenius CF; Andersson TB; Alves PM; Batzl-Hartmann C; Björquist P; Carrondo MJ; Chesne C; Coecke S; Edsbagge J; Fredriksson JM; Gerlach JC; Heinzle E; Ingelman-Sundberg M; Johansson I; Küppers-Munther B; Müller-Vieira U; Noor F; Zeilinger K
    Altern Lab Anim; 2011 May; 39(2):147-71. PubMed ID: 21639679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells.
    Cipriano M; Correia JC; Camões SP; Oliveira NG; Cruz P; Cruz H; Castro M; Ruas JL; Santos JM; Miranda JP
    Arch Toxicol; 2017 Jun; 91(6):2469-2489. PubMed ID: 27909741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.